M Carolina Danovaro-Holliday1, Dale A Rhoda2, Mona Lacoul3, Mary L Prier2, Jhalak Sharma Gautam4, Tara Nath Pokhrel4, Sameer Mani Dixit5, Rajesh Man Rajbhandari5, Anindya Sekhar Bose6,3. 1. Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization (WHO), 20, Ave Appia, 1211, Geneva, Switzerland. danovaroc@who.int. 2. Biostat Global Consulting, Worthington, OH, USA. 3. Country Office Nepal, WHO, Kathmandu, Nepal. 4. Family Welfare Division, Department of Health Services, Government of Nepal, Kathmandu, Nepal. 5. Center for Molecular Dynamics (CMDN), Kathmandu, Nepal. 6. Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization (WHO), 20, Ave Appia, 1211, Geneva, Switzerland.
Abstract
BACKGROUND: Following the 2015 earthquake, a measles-rubella (MR) supplementary immunization activity (SIA), in four phases, was implemented in Nepal in 2015-2016. A post-campaign coverage survey (PCCS) was then conducted in 2017 to assess SIA performance and explore factors that were associated with vaccine uptake. METHODS: A household survey using stratified multi-stage probability sampling was conducted to assess coverage for a MR dose in the 2015-2016 SIA in Nepal. Logistic regression was then used to identify factors related to vaccine uptake. RESULTS: Eleven thousand two hundred fifty-three households, with 4870 eligible children provided information on vaccination during the 2015-2016 MR SIA. Overall coverage of measles-rubella vaccine was 84.7% (95% CI: 82.0-87.0), but varied between 77.5% (95% CI: 72.0, 82.2) in phase-3, of 21 districts vaccinated in Feb-Mar 2016, to 97.7% (CI: 95.4, 98.9) in phase-4, of the last seven mountainous districts vaccinated in Mar-Apr 2016. Coverage in rural areas was higher at 85.6% (CI: 81.9, 88.8) than in urban areas at 79.0% (CI: 75.5, 82.1). Of the 4223 children whose caregivers knew about the SIA, 96.5% received the MR dose and of the 647 children whose caregivers had not heard about the campaign, only 1.8% received the MR dose. CONCLUSIONS: The coverage in the 2015-2016 MR SIA in Nepal varied by geographical region with rural areas achieving higher coverage than urban areas. The single most important predictor of vaccination was the caregiver being informed in advance about the vaccination campaign. Enhanced efforts on social mobilization for vaccination have been used in Nepal since this survey, notably for the most recent 2020 MR campaign.
BACKGROUND: Following the 2015 earthquake, a measles-rubella (MR) supplementary immunization activity (SIA), in four phases, was implemented in Nepal in 2015-2016. A post-campaign coverage survey (PCCS) was then conducted in 2017 to assess SIA performance and explore factors that were associated with vaccine uptake. METHODS: A household survey using stratified multi-stage probability sampling was conducted to assess coverage for a MR dose in the 2015-2016 SIA in Nepal. Logistic regression was then used to identify factors related to vaccine uptake. RESULTS: Eleven thousand two hundred fifty-three households, with 4870 eligible children provided information on vaccination during the 2015-2016 MR SIA. Overall coverage of measles-rubella vaccine was 84.7% (95% CI: 82.0-87.0), but varied between 77.5% (95% CI: 72.0, 82.2) in phase-3, of 21 districts vaccinated in Feb-Mar 2016, to 97.7% (CI: 95.4, 98.9) in phase-4, of the last seven mountainous districts vaccinated in Mar-Apr 2016. Coverage in rural areas was higher at 85.6% (CI: 81.9, 88.8) than in urban areas at 79.0% (CI: 75.5, 82.1). Of the 4223 children whose caregivers knew about the SIA, 96.5% received the MR dose and of the 647 children whose caregivers had not heard about the campaign, only 1.8% received the MR dose. CONCLUSIONS: The coverage in the 2015-2016 MR SIA in Nepal varied by geographical region with rural areas achieving higher coverage than urban areas. The single most important predictor of vaccination was the caregiver being informed in advance about the vaccination campaign. Enhanced efforts on social mobilization for vaccination have been used in Nepal since this survey, notably for the most recent 2020 MR campaign.
Authors: Sudhir Khanal; Tika Ram Sedai; Ganga Ram Choudary; Jagat Narain Giri; Rajendra Bohara; Rajendra Pant; Mukunda Gautam; Umid M Sharapov; James L Goodson; James Alexander; Alya Dabbagh; Peter Strebel; Robert T Perry; Sunil Bah; Nihal Abeysinghe; Arun Thapa Journal: MMWR Morb Mortal Wkly Rep Date: 2016-03-04 Impact factor: 17.586
Authors: Rania A Tohme; Jeannot François; Kathleen Wannemuehler; Roc Magloire; M Carolina Danovaro-Holliday; Brendan Flannery; Kathleen F Cavallaro; David L Fitter; Nora Purcell; Amber Dismer; Jordan W Tappero; John F Vertefeuille; Terri B Hyde Journal: Trop Med Int Health Date: 2014-07-16 Impact factor: 2.622
Authors: John Ndegwa Wagai; Dale Rhoda; Mary Prier; Mary Kay Trimmer; Caitlin B Clary; Joseph Oteri; Bassey Okposen; Adeyemi Adeniran; Carolina Danovaro-Holliday; Felicity Cutts Journal: PLoS One Date: 2021-02-26 Impact factor: 3.240
Authors: Heather M Scobie; Michael Edelstein; Edward Nicol; Ana Morice; Nargis Rahimi; Noni E MacDonald; M Carolina Danovaro-Holliday; Jaleela Jawad Journal: Vaccine Date: 2020-09-17 Impact factor: 3.641